AGF Management Ltd. Has $2.90 Million Holdings in DENTSPLY SIRONA Inc. $XRAY

AGF Management Ltd. grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 22.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 228,155 shares of the medical instruments supplier’s stock after buying an additional 41,731 shares during the quarter. AGF Management Ltd.’s holdings in DENTSPLY SIRONA were worth $2,895,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Arizona State Retirement System boosted its stake in DENTSPLY SIRONA by 1.4% in the third quarter. Arizona State Retirement System now owns 58,952 shares of the medical instruments supplier’s stock valued at $748,000 after buying an additional 807 shares in the last quarter. True Wealth Design LLC lifted its holdings in shares of DENTSPLY SIRONA by 49.7% in the third quarter. True Wealth Design LLC now owns 3,557 shares of the medical instruments supplier’s stock worth $45,000 after acquiring an additional 1,181 shares during the last quarter. Sivia Capital Partners LLC boosted its stake in shares of DENTSPLY SIRONA by 5.3% in the 3rd quarter. Sivia Capital Partners LLC now owns 25,774 shares of the medical instruments supplier’s stock valued at $327,000 after purchasing an additional 1,293 shares in the last quarter. AlphaQuest LLC grew its holdings in shares of DENTSPLY SIRONA by 2.5% during the 2nd quarter. AlphaQuest LLC now owns 52,817 shares of the medical instruments supplier’s stock valued at $839,000 after purchasing an additional 1,294 shares during the last quarter. Finally, Empowered Funds LLC increased its position in DENTSPLY SIRONA by 8.8% during the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock worth $244,000 after purchasing an additional 1,320 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier sold 82,200 shares of DENTSPLY SIRONA stock in a transaction on Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.50% of the stock is currently owned by company insiders.

DENTSPLY SIRONA Price Performance

Shares of XRAY opened at $12.53 on Thursday. The business has a 50-day moving average of $11.82 and a 200-day moving average of $12.69. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The company has a market capitalization of $2.50 billion, a price-to-earnings ratio of -2.83, a price-to-earnings-growth ratio of 0.95 and a beta of 1.01. DENTSPLY SIRONA Inc. has a 1 year low of $9.85 and a 1 year high of $19.77.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.08). DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The company had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.33 million. During the same quarter in the previous year, the company earned $0.50 earnings per share. The business’s revenue was down 4.9% on a year-over-year basis. As a group, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.1%. The ex-dividend date of this dividend was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio is currently -14.48%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Barclays initiated coverage on shares of DENTSPLY SIRONA in a research note on Monday, December 8th. They set an “underweight” rating and a $12.00 target price on the stock. UBS Group reduced their price objective on DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating on the stock in a research report on Tuesday. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Tuesday, December 16th. JPMorgan Chase & Co. cut their price target on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Friday, November 7th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, January 21st. Two investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Reduce” and an average target price of $14.25.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.